Page last updated: 2024-08-17

nad and Huntington Disease

nad has been researched along with Huntington Disease in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (12.50)29.6817
2010's5 (62.50)24.3611
2020's2 (25.00)2.80

Authors

AuthorsStudies
Fathi, M; Hajibeygi, R; Jazi, K; Klegeris, A; McElhinney, A; Sayehmiri, F; Shool, S; Sodeifian, F; Tavasol, A; Tavirani, MR; Vakili, K; Yaghoobpoor, S1
Barrientos, A; Bazylianska, V; Nyvltova, E; Pinkerton, M; Ruetenik, A1
Athilingam, T; Sharma, RK; Singh, V; Sinha, N; Sinha, P; Thakur, AK1
Kumar, A; Mishra, J1
Calvo-Silva, FJ; Fernández-Valverde, F; García-Morales, J; Orozco-Ibarra, M; Serrano-García, N1
Digman, MA; Marsh, JL; Sameni, S; Syed, A1
Cai, AL; Sheline, CT; Shi, C; Zhang, W; Zhu, J1
Cheng, R; Hart, AC; Stockwell, BR; Varma, H; Voisine, C1

Reviews

1 review(s) available for nad and Huntington Disease

ArticleYear
Dynamic changes in metabolites of the kynurenine pathway in Alzheimer's disease, Parkinson's disease, and Huntington's disease: A systematic Review and meta-analysis.
    Frontiers in immunology, 2022, Volume: 13

    Topics: 3-Hydroxyanthranilic Acid; Adenosine; Alzheimer Disease; Humans; Huntington Disease; Hydroxyindoleacetic Acid; Kynurenic Acid; Kynurenine; NAD; Niacinamide; Parkinson Disease; Tryptophan

2022

Other Studies

7 other study(ies) available for nad and Huntington Disease

ArticleYear
Salvage NAD+ biosynthetic pathway enzymes moonlight as molecular chaperones to protect against proteotoxicity.
    Human molecular genetics, 2021, 05-17, Volume: 30, Issue:8

    Topics: Amino Acid Sequence; Biosynthetic Pathways; Humans; Huntington Disease; Microscopy, Fluorescence; Models, Genetic; Molecular Chaperones; NAD; Nicotinamide-Nucleotide Adenylyltransferase; Parkinson Disease; Peptides; Proteostasis; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Sequence Homology, Amino Acid; Trinucleotide Repeats

2021
NMR Spectroscopy-based Metabolomics of Drosophila Model of Huntington's Disease Suggests Altered Cell Energetics.
    Journal of proteome research, 2017, 10-06, Volume: 16, Issue:10

    Topics: Animals; Disease Models, Animal; Drosophila melanogaster; Energy Metabolism; Humans; Huntingtin Protein; Huntington Disease; Magnetic Resonance Spectroscopy; Metabolomics; NAD; Neurons; Peptides

2017
Improvement of mitochondrial NAD(+)/FAD(+)-linked state-3 respiration by caffeine attenuates quinolinic acid induced motor impairment in rats: implications in Huntington's disease.
    Pharmacological reports : PR, 2014, Volume: 66, Issue:6

    Topics: Animals; Antioxidants; Caffeine; Cell Respiration; Corpus Striatum; Disease Models, Animal; Dose-Response Relationship, Drug; Flavin-Adenine Dinucleotide; Huntington Disease; Mitochondria; NAD; Neuroprotective Agents; Neurotoxicity Syndromes; Oxidative Stress; Quinolinic Acid; Rats

2014
Striatal mitochondria response to 3-nitropropionic acid and fish oil treatment.
    Nutritional neuroscience, 2018, Volume: 21, Issue:2

    Topics: Animals; Antioxidants; Corpus Striatum; Cytochrome-c Peroxidase; Disease Models, Animal; Dose-Response Relationship, Drug; Electron Transport Complex II; Electron Transport Complex IV; Fish Oils; Huntington Disease; In Situ Nick-End Labeling; Lipid Peroxidation; Male; Mitochondria; NAD; Neuroprotective Agents; Nitro Compounds; Oxidative Stress; Propionates; Rats; Rats, Wistar

2018
The phasor-FLIM fingerprints reveal shifts from OXPHOS to enhanced glycolysis in Huntington Disease.
    Scientific reports, 2016, 10-07, Volume: 6

    Topics: Animals; Animals, Genetically Modified; Cell Nucleus; Drosophila; Eye; Gene Expression Regulation; Glycolysis; HEK293 Cells; Humans; Huntingtin Protein; Huntington Disease; Microscopy, Fluorescence; NAD; Oxidative Stress; Phosphorylation; Trinucleotide Repeat Expansion

2016
Mitochondrial inhibitor models of Huntington's disease and Parkinson's disease induce zinc accumulation and are attenuated by inhibition of zinc neurotoxicity in vitro or in vivo.
    Neuro-degenerative diseases, 2013, Volume: 11, Issue:1

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Carrier Proteins; Cation Transport Proteins; Cell Death; Cells, Cultured; Cerebral Cortex; Dihydroxyacetone Phosphate; Disease Models, Animal; Drug Interactions; Embryo, Mammalian; Fructose-Bisphosphatase; Humans; Huntington Disease; Male; Matrix Metalloproteinase 16; Membrane Proteins; Membrane Transport Proteins; Mental Disorders; Mice; Mice, Inbred C57BL; Mice, Neurologic Mutants; Mice, Transgenic; NAD; Neurons; Niacinamide; Nitro Compounds; Oxidopamine; Parkinson Disease; Propionates; Pyruvic Acid; Rats; Rats, Long-Evans; Tyrosine 3-Monooxygenase; Zinc

2013
Inhibitors of metabolism rescue cell death in Huntington's disease models.
    Proceedings of the National Academy of Sciences of the United States of America, 2007, Sep-04, Volume: 104, Issue:36

    Topics: Adenosine Triphosphate; Animals; Caspases; Cell Death; Cell Line; Disease Models, Animal; Drosophila melanogaster; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Glycolysis; Huntington Disease; Mitochondria; Mutation; NAD; Neurons; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Rotenone; Signal Transduction

2007